IL315355A - Crystalline dipeptides useful in the synthesis of elamipretide - Google Patents

Crystalline dipeptides useful in the synthesis of elamipretide

Info

Publication number
IL315355A
IL315355A IL315355A IL31535524A IL315355A IL 315355 A IL315355 A IL 315355A IL 315355 A IL315355 A IL 315355A IL 31535524 A IL31535524 A IL 31535524A IL 315355 A IL315355 A IL 315355A
Authority
IL
Israel
Prior art keywords
compound
formula
suspension
charge
crystalline
Prior art date
Application number
IL315355A
Other languages
English (en)
Hebrew (he)
Original Assignee
Stealth Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Inc filed Critical Stealth Biotherapeutics Inc
Publication of IL315355A publication Critical patent/IL315355A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL315355A 2018-04-02 2019-03-28 Crystalline dipeptides useful in the synthesis of elamipretide IL315355A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862651430P 2018-04-02 2018-04-02
PCT/US2019/024617 WO2019195080A1 (en) 2018-04-02 2019-03-28 Crystalline dipeptides useful in the synthesis of elamipretide

Publications (1)

Publication Number Publication Date
IL315355A true IL315355A (en) 2024-11-01

Family

ID=68101313

Family Applications (2)

Application Number Title Priority Date Filing Date
IL315355A IL315355A (en) 2018-04-02 2019-03-28 Crystalline dipeptides useful in the synthesis of elamipretide
IL277718A IL277718B2 (en) 2018-04-02 2019-03-28 Crystalline dipeptides used in the synthesis of almipretide

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL277718A IL277718B2 (en) 2018-04-02 2019-03-28 Crystalline dipeptides used in the synthesis of almipretide

Country Status (13)

Country Link
US (4) US10975118B2 (https=)
EP (2) EP3774844B1 (https=)
JP (2) JP7350007B2 (https=)
KR (2) KR102753323B1 (https=)
CN (2) CN112292388B (https=)
AU (1) AU2019249121B2 (https=)
CA (2) CA3280578A1 (https=)
DK (1) DK3774844T3 (https=)
ES (1) ES2941266T3 (https=)
FI (1) FI3774844T3 (https=)
IL (2) IL315355A (https=)
PT (1) PT3774844T (https=)
WO (1) WO2019195080A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115160402A (zh) * 2016-03-11 2022-10-11 隐形生物治疗公司 结晶盐形式
PT3774844T (pt) 2018-04-02 2023-03-28 Stealth Biotherapeutics Inc Dipeptídeos cristalinos úteis na síntese de elamipretida
CN117881411A (zh) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 用于眼部药物的延长释放药物递送系统和使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4711166B2 (ja) * 2004-08-03 2011-06-29 株式会社 液晶先端技術開発センター 結晶化装置、および結晶化方法
CA3022250A1 (en) * 2012-12-12 2014-06-12 Ariad Pharmaceuticals, Inc. Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride
CN104945453B (zh) * 2014-03-28 2018-06-26 江苏天士力帝益药业有限公司 吡唑衍生物的多晶型物
WO2016001042A1 (en) 2014-06-30 2016-01-07 Flamma S.P.A. Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
US10633415B2 (en) * 2015-03-06 2020-04-28 Stealth Biotherapeutics Corp Processes for preparing pharmaceutically relevant peptides
CA3254279A1 (en) * 2015-06-03 2025-03-18 Triastek, Inc. PHARMACEUTICAL FORMS AND RELATED USES
CN115160402A (zh) * 2016-03-11 2022-10-11 隐形生物治疗公司 结晶盐形式
CN110087667A (zh) 2016-08-16 2019-08-02 隐形生物治疗公司 Elamipretide的基于N-羧基酸酐的规模合成
CN110914287A (zh) * 2017-04-05 2020-03-24 隐形生物治疗公司 Boc-d-arg-dmt-lys-(boc)-phe-nh2的结晶盐形式
PT3774844T (pt) 2018-04-02 2023-03-28 Stealth Biotherapeutics Inc Dipeptídeos cristalinos úteis na síntese de elamipretida

Also Published As

Publication number Publication date
US20250122238A1 (en) 2025-04-17
AU2019249121B2 (en) 2024-05-02
CA3280578A1 (en) 2025-10-30
AU2019249121A1 (en) 2020-11-26
EP3774844A1 (en) 2021-02-17
KR102753323B1 (ko) 2025-01-09
EP4219523A3 (en) 2023-08-09
IL277718B1 (en) 2024-10-01
ES2941266T3 (es) 2023-05-19
US20200283476A1 (en) 2020-09-10
DK3774844T3 (da) 2023-04-03
KR20210005042A (ko) 2021-01-13
EP4219523A2 (en) 2023-08-02
CN112292388B (zh) 2024-04-19
EP3774844A4 (en) 2021-12-15
US12018094B2 (en) 2024-06-25
JP2021520357A (ja) 2021-08-19
CA3095869C (en) 2025-10-21
CN118206614A (zh) 2024-06-18
JP7663642B2 (ja) 2025-04-16
EP3774844B1 (en) 2023-02-22
JP2023165756A (ja) 2023-11-17
PT3774844T (pt) 2023-03-28
CN112292388A (zh) 2021-01-29
JP7350007B2 (ja) 2023-09-25
KR20250010134A (ko) 2025-01-20
IL277718B2 (en) 2025-02-01
US20210292274A1 (en) 2021-09-23
FI3774844T3 (fi) 2023-04-04
IL277718A (en) 2020-11-30
US11560404B2 (en) 2023-01-24
US10975118B2 (en) 2021-04-13
CA3095869A1 (en) 2019-10-10
WO2019195080A1 (en) 2019-10-10
US20230203093A1 (en) 2023-06-29

Similar Documents

Publication Publication Date Title
US20250122238A1 (en) Crystalline dipeptides useful in the synthesis of elamipretide
WO2016180275A1 (zh) Ahu-377的制备方法、ahu-377中间体及ahu-377中间体的制备方法
WO2019026014A1 (en) METHODS FOR PREPARING LIFITEGRAST AND ITS INTERMEDIATES
CN112272665B (zh) 制备立他司特的方法
WO2015110885A1 (en) A process for preparation of (2s,5r)-6-sulphooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
US20240262805A1 (en) Method for producing compound or pharmaceutically acceptable salt thereof
HK40097695A (en) Crystalline dipeptides useful in the synthesis of elamipretide
HRP20050039A2 (en) Crystal forms of olanzapine and processes for their preparation
JP2025501596A (ja) 酸化型グルタチオン及びその結晶形並びに不純物の調製方法
HK40045731B (en) Crystalline dipeptides useful in the synthesis of elamipretide
HK40045731A (en) Crystalline dipeptides useful in the synthesis of elamipretide
HK40046563A (en) Crystalline dipeptides useful in the synthesis of elamipretide
CN116265466A (zh) 调节用途依赖性的电压门控的钠通道的化合物的合成
JP6336166B2 (ja) イミダフェナシンの新規中間体、その製造方法及びそれを用いたイミダフェナシンの製造方法
CN118475589A (zh) 一种神经激肽-1拮抗剂前药化合物的晶型
JP4416111B2 (ja) 2,3−ジアミノピリジン誘導体の製造方法
HK40046563B (zh) 用於合成elamipretide的结晶二肽
CN120665002A (zh) 一种3-氨基吡咯烷-1-羧酸叔丁酯的制备方法及其应用
WO2013054273A9 (en) Process for the preparation of agomelatine
JPH10195075A (ja) Z−バラシクロビルの製造方法
IE52967B1 (en) Chemical process